Carfilzomib - Proteasome Inhibitor. CAS# 868540-17-4 size:10 mg solid more specifically

more specifically

and in vivo in monkeys and humans

(2015) Blood

resulting in downregulation of antiapoptotic and upregulation of proapoptotic proteins

IP administration of SR10067 was used at 30 mg/kg to mice

Carfilzomib - Proteasome Inhibitor. CAS# 868540-17-4 size:10 mg solid more specificallyCarfilzomib, CAS No. 868540 17 4, is a selective, irreversible proteasome inhibitor (over 80% inhibition at doses of 10 nM and above). In models of multiple myeloma, Carfilzomib potently bound and specifically inhibited the chymotrypsin like proteasome and immunoproteasome activities, resulting in accumulation of ubiquitinated substrates. It induced a dose and time dependent inhibition of proliferation, ultimately leading to apoptosis. It also